Table 2.
Age | Disease duration | BASDAI | ESR | CRP | ASDAS | BASFI | PINP Z | sCTX Z | OC Z | LS BMD T | Hip BMD T | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Disease duration (years) | 0.600a | – | ||||||||||
BASDAI (range 0–10) | NS | NS | – | |||||||||
ESR (mm/h) | NS | NS | NS | – | ||||||||
CRP (mg/L) | NS | NS | NS | 0.693a | – | |||||||
ASDAS | NS | 0.187a | 0.651a | 0.374a | 0.668a | – | ||||||
BASFI (range 0–10) | NS | 0.203a | 0.561a | NS | NS | 0.472a | – | |||||
PINP Z-score | 0.362a | 0.266a | NS | NS | NS | NS | NS | – | ||||
sCTX Z-score | NS | 0.200a | NS | NS | NS | NS | NS | 0.443a | – | |||
OC Z-score | NS | NS | NS | NS | NS | NS | NS | 0.578a | 0.601a | – | ||
LS BMD T-score | NS | NS | 0.205a | NS | NS | NS | NS | NS | NS | NS | – | |
Hip BMD T-score | NS | NS | NS | NS | NS | NS | NS | NS | −0.380a | −0.272a | 0.626a | – |
25OHvitD (nmol/L) | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS |
aStatistically significant correlation (p < 0.05)
See Table 1 for definitions